Comparative Evaluation of Combinatory Interaction between Endocannabinoid System Compounds and Poly-L-lysine against
Anti-Infective Agents
/ chemistry
Arachidonic Acids
/ pharmacology
Biofilms
/ drug effects
Dental Plaque
/ prevention & control
Drug Combinations
Endocannabinoids
/ chemistry
Microbial Sensitivity Tests
Microbial Viability
/ drug effects
Oleic Acids
/ pharmacology
Polylysine
/ chemistry
Polyunsaturated Alkamides
/ pharmacology
Streptococcus mutans
/ drug effects
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2020
2020
Historique:
received:
05
09
2019
revised:
09
12
2019
accepted:
11
01
2020
entrez:
21
2
2020
pubmed:
23
2
2020
medline:
1
12
2020
Statut:
epublish
Résumé
Endocannabinoid/endocannabinoid-like (EC/EC-like) are natural endogenous compounds which have been found to affect MRSA pathogenicity. Our previous studies showed that EC/EC-like was able to impair staphylococcal biofilm formation and maintenance as well as to alter biofilm-associated virulence factors. In the present study, we investigated the combinatory effect of the selected EC/EC-like with a natural antimicrobial agent, poly-L-lysine, on cariogenic bacteria
Identifiants
pubmed: 32076613
doi: 10.1155/2020/7258380
pmc: PMC7013284
doi:
Substances chimiques
Anti-Infective Agents
0
Arachidonic Acids
0
Drug Combinations
0
Endocannabinoids
0
Oleic Acids
0
Polyunsaturated Alkamides
0
oleoylethanolamide
1HI5J9N8E6
Polylysine
25104-18-1
anandamide
UR5G69TJKH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7258380Informations de copyright
Copyright © 2020 Mark Feldman et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest regarding the publication of this paper.
Références
Nat Neurosci. 2014 Feb;17(2):164-74
pubmed: 24473264
J Amino Acids. 2014;2014:672367
pubmed: 24660058
Pharmacol Rev. 2006 Sep;58(3):389-462
pubmed: 16968947
Lett Appl Microbiol. 2007 Jul;45(1):13-8
pubmed: 17594454
Neuroimmunomodulation. 2017;24(4-5):183-199
pubmed: 29151103
Probiotics Antimicrob Proteins. 2009 Dec;1(2):143
pubmed: 26783169
PLoS One. 2009;4(3):e4989
pubmed: 19330032
J Biomed Biotechnol. 2012;2012:618081
pubmed: 21941436
Microb Pathog. 2017 Nov;112:156-163
pubmed: 28964825
Nutr Rev. 1980 Feb;38(2):65-73
pubmed: 7383442
Nature. 2002 Jan 24;415(6870):389-95
pubmed: 11807545
Biomacromolecules. 2011 Oct 10;12(10):3581-91
pubmed: 21846110
Biochim Biophys Acta. 1999 Dec 15;1462(1-2):1-10
pubmed: 10590299
PLoS One. 2014 Mar 12;9(3):e91736
pubmed: 24622055
Sci Rep. 2017 Jan 27;7:41362
pubmed: 28128290
Sci Rep. 2018 Dec 6;8(1):17696
pubmed: 30523307
J Med Microbiol. 2018 Jun;67(6):838-845
pubmed: 29633934
Cannabis Cannabinoid Res. 2017 May 01;2(1):96-104
pubmed: 28861509
Caries Res. 2001 Nov-Dec;35(6):412-20
pubmed: 11799281
Biomed Res Int. 2019 Jan 2;2019:7602343
pubmed: 30719447
Am J Respir Crit Care Med. 2013 Sep 15;188(6):703-9
pubmed: 23947381
J Med Chem. 1997 Feb 28;40(5):659-67
pubmed: 9057852
J Antibiot (Tokyo). 1984 Nov;37(11):1449-55
pubmed: 6392269
J Clin Periodontol. 1993 May;20(5):335-9
pubmed: 8501273
Food Nutr Res. 2016 Jun 15;60:31891
pubmed: 27312785
J Food Sci. 2012 Jul;77(7):M405-11
pubmed: 22670620
J Bacteriol. 1960 Nov;80(5):590-4
pubmed: 16561873
Antimicrob Agents Chemother. 2012 Apr;56(4):1756-61
pubmed: 22252803
Appl Environ Microbiol. 2010 Feb;76(3):751-6
pubmed: 20023092
PLoS One. 2014 May 05;9(5):e93225
pubmed: 24796422
Infect Dis Obstet Gynecol. 2012;2012:284762
pubmed: 23024575
Regul Toxicol Pharmacol. 2003 Apr;37(2):328-40
pubmed: 12726761